| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 1997;114:948-956
© 1997 Mosby, Inc.
GENERAL THORACIC SURGERY |
Received for publication May 6, 1997 Revisions requested June 16, 1997 Revisions received August 18, 1997 Accepted for publication August 19, 1997 Address for reprints: Nasser K. Altorki, MD, Director, Division of Thoracic Surgery, Department of Cardiothoracic Surgery, The New York Hospital–Cornell Medical Center, 525 East 68th St., New York, NY 10021.
Abstract
Objective: The role of en bloc esophagectomy in the surgical treatment of patients with locally advanced esophageal cancer is not well defined. This report attempts to elucidate its impact on survival, in comparison with less extensive resection, among patients with stage III disease. Methods: A prospectively established database was retrospectively analyzed. Results: One hundred twenty-eight patients underwent esophagectomy for carcinoma of the thoracic esophagus between 1988 and 1996 (78 underwent en bloc resection and 50 underwent standard resection). The 30-day and hospital mortality rates were 3.9% and 5.4%, respectively, comparable for the two procedures. Fifty-four patients had stage III disease. Overall 4-year survival was 34.5% after en bloc resection, with a median survival of 27 months ( n = 33), and 11% after standard resection ( n = 21), with a median survival of 12 months ( p = 0.007). Among patients with stage III disease undergoing a complete resection, 4-year survivals were 36.7% and 0% after en bloc and standard resections, respectively ( p = 0.001). Eighty-six of 128 patients had nodal metastasis. Three-year survivals for patients with N1 disease were 33.9% and 13% after en bloc and standard resections, respectively ( p = 0.02). Conclusion: Among patients with stage III esophageal cancer, en bloc resection appears to significantly improve survival compared with lesser resections. This improvement in survival may be attributable to resection of nodal disease.
This article has been cited by other articles:
|
|
 |
|
  C. Rizzetto, S.R. DeMeester, J.A. Hagen, C.G. Peyre, J.C. Lipham, and T.R. DeMeester En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma. J. Thorac. Cardiovasc. Surg., June 1, 2008; 135(6): 1228 - 1236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Guo, H. Zhu, Y. Xi, B. Zhang, L. Li, Y. Huang, J. Zhang, Z. Fu, G. Yang, S. Yuan, et al. Diagnostic and Prognostic Value of 18F-FDG PET/CT for Patients with Suspected Recurrence from Squamous Cell Carcinoma of the Esophagus J. Nucl. Med., August 1, 2007; 48(8): 1251 - 1258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. H. Kang, Y. T. Kim, S.-H. Jeon, S.-W. Sung, and J. H. Kim Lymphadenectomy extent is closely related to long-term survival in esophageal cancer Eur. J. Cardiothorac. Surg., February 1, 2007; 31(2): 154 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Gee and D. W. Rattner Management of Gastroesophageal Tumors Oncologist, February 1, 2007; 12(2): 175 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Lee, K.-E. Lee, Y.-H. Im, W. K. Kang, K. Park, K. Kim, and Y. M. Shim Adjuvant Chemotherapy with 5-Fluorouracil and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma Ann. Thorac. Surg., October 1, 2005; 80(4): 1170 - 1175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Johansson, T. R. DeMeester, J. A. Hagen, S. R. DeMeester, J. H. Peters, S. Oberg, and C. G. Bremner En Bloc vs Transhiatal Esophagectomy for Stage T3 N1 Adenocarcinoma of the Distal Esophagus Arch Surg, June 1, 2004; 139(6): 627 - 633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Koshy, N. Esiashvilli, J. C. Landry, C. R. Thomas Jr., and R. H. Matthews Multiple Management Modalities in Esophageal Cancer: Epidemiology, Presentation and Progression, Work-up, and Surgical Approaches Oncologist, April 1, 2004; 9(2): 137 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Keresztes, J. L. Port, M. W. Pasmantier, R. J. Korst, and N. K. Altorki Preoperative chemotherapy for esophageal cancer with paclitaxel and carboplatin: Results of a phase II trial J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1603 - 1608. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Schroder, S.P. Monig, S.E. Baldus, C. Gutschow, P.M. Schneider, and A.H. Holscher Frequency of Nodal Metastases to the Upper Mediastinum in Barrett's Cancer Ann. Surg. Oncol., October 1, 2002; 9(8): 807 - 811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Imdahl, G. Bognar, J. Schulte-Monting, U. Schoffel, E.H. Farthmann, and C. Ihling Predictive factors for response to neoadjuvant therapy in patients with oesophageal cancer Eur. J. Cardiothorac. Surg., April 1, 2002; 21(4): 657 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W.C. Entwistle III and M. Goldberg Multimodality therapy for resectable cancer of the thoracic esophagus Ann. Thorac. Surg., March 1, 2002; 73(3): 1009 - 1015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Swanson, H. F. Batirel, R. Bueno, M. T. Jaklitsch, J. M. Lukanich, E. Allred, S. J. Mentzer, and D. J. Sugarbaker Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma Ann. Thorac. Surg., December 1, 2001; 72(6): 1918 - 1925. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Hagen and T. R. DeMeester Esophageal adenocarcinoma Ann. Thorac. Surg., October 1, 2001; 72(4): 1430 - 1432. [Full Text] [PDF]
|
|
|
|
|
|
H. Igaki, H. Kato, Y. Tachimori, H. Sato, H. Daiko, and Y. Nakanishi Prognostic evaluation for squamous cell carcinomas of the lower thoracic esophagus treated with three-field lymph node dissection Eur. J. Cardiothorac. Surg., June 1, 2001; 19(6): 887 - 893. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S P L Dexter, H Sue-Ling, M J McMahon, P Quirke, N Mapstone, and I G Martin Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer Gut, May 1, 2001; 48(5): 667 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Flamen, A. Lerut, E. Van Cutsem, J. P. Cambier, A. Maes, W. De Wever, M. Peeters, P. De Leyn, D. Van Raemdonck, and L. Mortelmans The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer J. Thorac. Cardiovasc. Surg., December 1, 2000; 120(6): 1085 - 1092. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Lerut, W. Coosemans, P. De Leyn, D. Van Raemdonck, G. Deneffe, and G. Decker Treatment of Esophageal Carcinoma* Chest, December 1, 1999; 116(suppl_3): 463S - 465S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. van de Ven, P. De Leyn, W. Coosemans, D. Van Raemdonck, and T. Lerut Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction Eur. J. Cardiothorac. Surg., June 1, 1999; 15(6): 769 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J.R. Dalrymple-Hay, K. B. Evans, and R. E. Lea Oesophagectomy for carcinoma of the oesophagus and oesophagogastric junction Eur. J. Cardiothorac. Surg., May 1, 1999; 15(5): 626 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Nigro, S. R. DeMeester, J. A. Hagen, T. R. DeMeester, J. H. Peters, M. Kiyabu, G. M. R. Campos, S. Oberg, O. Gastal, P. F. Crookes, et al. NODE STATUS IN TRANSMURAL ESOPHAGEAL ADENOCARCINOMA AND OUTCOME AFTER EN BLOC ESOPHAGECTOMY J. Thorac. Cardiovasc. Surg., May 1, 1999; 117(5): 960 - 968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Lerut Esophageal surgery at the end of the millennium J. Thorac. Cardiovasc. Surg., July 1, 1998; 116(1): 1 - 20. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
